skip to main content

S. 164 (117th): Advancing Education on Biosimilars Act of 2021

React to this bill with an emoji

(About Ads | Hide These Ads)

A bill to educate health care providers and the public on biosimilar biological products, and for other purposes.

Sponsor and status

Photo of sponsor Margaret “Maggie” Hassan

Margaret “Maggie” Hassan

Sponsor. Senator for New Hampshire. Democrat.

Thumbnail of bill text
Read Text »
Last Updated: Apr 16, 2021
Length: 2 pages
Introduced
Feb 2, 2021
117th Congress (2021–2023)
Status

Enacted — Signed by the President on Apr 23, 2021

This bill was enacted after being signed by the President on April 23, 2021.

Law
Pub.L. 117-8
Cosponsors

1 Cosponsor (1 Republican)

Source
Congress.gov

Incorporated legislation

This bill incorporates provisions from:

H.R. 1873: Advancing Education on Biosimilars Act of 2021

Introduced on Mar 12, 2021. 100% incorporated. (compare text)

H.R. 19: Lower Costs, More Cures Act of 2021

Introduced on Apr 21, 2021. 2% incorporated. (compare text)

History

Feb 2, 2021
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

Mar 3, 2021
 
Passed Senate (House next)

The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made.

Read Updated Text » See Changes »

Mar 12, 2021
 
Text Published

Updated bill text was published as of Preprint (Suspension).

Read Updated Text » See Changes »

Apr 14, 2021
 
Passed House

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill.

thumbnail image of vote View Vote » Read Updated Text » See Changes »

Apr 23, 2021
 
Enacted — Signed by the President

The President signed the bill and it became law.

S. 164 (117th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number S. 164. This is the one from the 117th Congress.

This bill was introduced in the 117th Congress, which met from Jan 3, 2021 to Jan 3, 2023. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 164 — 117th Congress: Advancing Education on Biosimilars Act of 2021.” www.GovTrack.us. 2021. March 24, 2023 <https://www.govtrack.us/congress/bills/117/s164>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.